Muslim
The rapid ascent of GLP-1 receptor agonists—a class of drugs including Ozempic, Wegovy, and Mounjaro—has reshaped the landscape of obesity medicine. However, as demand outstrips supply and prices remain prohibitive for many, a shadowy "gray market" has flourished in the digital corners of the internet. A damning new report from the gender justice nonprofit UltraViolet has placed a spotlight on TikTok, accusing the platform of failing to adequately moderate the proliferation of unregulated GLP-1 sales, a trend that persists despite the platform’s high-profile ownership transition in early 2026.
The Anatomy of the Gray Market
The content analysis conducted by UltraViolet identified hundreds of TikTok accounts actively promoting unregulated GLP-1 drugs. These listings frequently peddle substances labeled as "research-grade" or "alternatives," which bypass the rigorous safety protocols mandated by the U.S. Food and Drug Administration (FDA). Even more concerning is the operational funnel these accounts utilize: instead of facilitating transactions on-platform, they leverage TikTok as a discovery engine, directing users to encrypted messaging services like WhatsApp, Discord, and Telegram to finalize illicit purchases.
The substances being traded are not limited to established brands. Researchers found significant promotion of non-FDA approved compounds, such as retatrutide. Despite updates to TikTok’s Community Guidelines and Terms of Service, the report confirms that this content remains easily accessible to users, whether they possess a registered account or are browsing anonymously. Perhaps most alarmingly, the platform’s own "Discover" feature actively facilitates this behavior, with auto-generated search suggestions that steer users toward the acquisition of these unregulated pharmaceuticals.
A Chronology of Neglect: Pre- and Post-Transition
The UltraViolet study was conducted in two distinct phases, providing a longitudinal look at the platform’s moderation efficacy during a period of tectonic corporate change.
Phase One (Late 2025): Prior to the ownership shift, researchers noted a pervasive presence of illicit drug marketing. Despite TikTok’s existing policies against "unofficial markets," the volume of content remained high.
The Transition (Early 2026): Following the sale of TikTok’s U.S. operations to an American board of investors, there was a brief period of operational recalibration. The platform updated its Community Guidelines and revised its Terms of Service in January 2026, signaling a potential shift in how the platform would govern its digital ecosystem.
Phase Two (Post-Transition 2026): To the researchers’ surprise, the transition did not yield a significant drop in harmful content. The "gray market" proved to be remarkably resilient. Even after the change in leadership, the platform continued to surface and recommend these posts through its curation algorithms. UltraViolet reported 202 specific accounts for policy violations; however, on average, only one-third of these reports resulted in account removal. This statistic suggests that while the platform has the mechanisms to police its content, the institutional will or technical capacity to stem the tide is significantly lacking.
Targeting Vulnerability: The Gendered Nature of the Crisis
One of the most disturbing aspects of the UltraViolet report is the targeted nature of these promotional campaigns. The study found that a substantial percentage of the illicit content was specifically curated to appeal to women. Account profiles frequently utilized photos of both real women and AI-generated avatars to build a sense of community and trust.
The messaging employed by these accounts is often predatory, blending commercial intent with toxic rhetoric surrounding weight loss and physical appearance. Researchers noted that much of the content included sexual imagery, unsubstantiated claims regarding women’s health, and harmful narratives that exacerbate body dysmorphia and eating disorders. By leveraging algorithmic targeting, these bad actors are effectively reaching vulnerable populations, offering "quick fixes" that carry significant, unverified health risks.
Policy vs. Reality: The Enforcement Gap
TikTok’s official stance on pharmaceuticals is governed by a complex framework of rules. The platform does not prohibit the general discussion of GLP-1s, nor does it ban pharmaceutical advertising that complies with regional regulations. However, its own stated policies explicitly forbid:
- Disordered Eating: The promotion of dangerous weight loss behaviors.
- Unsafe Marketing: Ads for products marketed as fat reducers, detoxes, or appetite suppressants.
- Prohibited Goods: Trading or marketing "high-risk" goods, or directing users to third-party platforms to acquire them.
The discrepancy between these policies and the lived experience of users is glaring. While TikTok’s advertising guidelines explicitly mention that products using "GLP-1" in their branding are restricted, the gray market circumvents these rules by utilizing coded language and migrating the transaction to private channels.
"We’ve seen this movie before," says Jenna Sherman, campaign director at UltraViolet. "Tech oligarchs gain control of huge swaths of the internet and shape the content and ads we see for their own political and financial gain at the cost of user safety and the public good. The twist this time is that we are in an unprecedented age of sophisticated algorithms, groundbreaking weight loss medications, and unhealthy weight-loss obsession. Altogether, it’s a disaster."
The Industry Context: A Landscape of Hyper-Marketing
The proliferation of unregulated drugs on TikTok occurs against a backdrop of aggressive, legal pharmaceutical marketing. In the first half of 2025 alone, industry giants Novo Nordisk (Wegovy, Ozempic) and Eli Lilly (Zepbound, Mounjaro) spent a combined $700 million on advertising. This saturation has created a "GLP-1 fever," where the ubiquity of the drugs in mainstream media creates a halo effect for the illicit market.
The competition has become increasingly litigious as well. Last week, Novo Nordisk filed a lawsuit against Eli Lilly, accusing the competitor of deceptive marketing practices. This corporate maneuvering highlights the massive financial stakes involved in the weight-loss market. For the average user, however, the result of this multi-billion-dollar marketing war is a social media feed inundated with weight-loss content that is often impossible to filter out, even for those in active recovery from eating disorders.
Implications for Public Health and Platform Governance
The failure to moderate the gray market has profound implications for public safety. Users consuming "research-grade" compounds are essentially acting as their own pharmacists, often without the necessary medical supervision, bloodwork, or dosage guidance. The risks include severe gastrointestinal distress, allergic reactions, and unknown long-term side effects from unregulated chemical purity.
For TikTok, the implications are equally significant. The platform’s failure to curtail this activity suggests that its "For You" algorithm—designed to maximize engagement—is inadvertently incentivizing dangerous behavior. By prioritizing content that garners high interest, the algorithm pushes users down a rabbit hole of weight-loss obsession, eventually leading them to the unregulated vendors.
As of the publication of this report, TikTok has declined to provide a formal response to the UltraViolet findings. The silence from the platform underscores the ongoing tension between corporate responsibility and the algorithmic pursuit of user retention.
Conclusion: A Call for Accountability
The evidence provided by UltraViolet serves as a critical warning. As pharmaceutical technology outpaces the ability of regulators and tech platforms to monitor its distribution, the burden of safety is falling squarely on the shoulders of the consumer.
The "gray market" on TikTok is not merely a policy failure; it is a symptom of a larger, systemic disregard for the health consequences of digital commerce. Until the platform implements more robust, proactive moderation strategies—and until the legal framework surrounding social media responsibility is strengthened—the trade of dangerous, unverified drugs will likely continue to thrive under the cover of the "For You" feed.
Disclaimer: The information contained in this article is provided for educational and informational purposes only and is not intended as health or medical advice. Always consult with a qualified physician or healthcare professional regarding any questions about medical conditions, weight loss, or the use of pharmaceutical products.
Iffa Jayyana
Ammar Sabilarrohman
